Advertisement: TTP
RealVNC mid banner careers
Barr Ellison Solicitors – commercial property
Advertisement: Cambridge Network
RealVNC mid-banner general
Advertisement: Simpsons Creative
Advertisement: EY Mid banner
Mid banner advertisement: BDO
Advertisement: Wild Knight Vodka
Advertisement: Mogrify
Advertisement: EBCam mid banner
Advertisement: RSM
ARM Innovation Hub
Advertisement: Kao Data Centre mid banner
6 August, 2020 - 10:43 By Tony Quested

MedTech startup raises $1.7 million for US push

Cambridge-born medical software business Transformative AI has raised a $1.7 million seed round.

Trade Mark and patent attorney Mathys & Squire reveals that the investment in its client was led by Tera Ventures and included funding from the Wellcome Trust and InHeath Ventures. The funding will support Transformative AI in obtaining FDA clearance for its first product. 

The team at Mathys & Squire, led by partner Dani Kramer, has worked with Transformative AI since its inception, and has been involved in the filing of a number of patent applications directed towards the prediction of cardiac events.

Transformative AI was formed in 2016 through Entrepreneur First’s startup programme and has since expanded to operate in the US, the UK and Estonia. 

Its predictive patient monitoring software allows healthcare providers to respond to life-threatening medical events before they occur, through the use of cutting-edge machine learning techniques.

The founders represent Cambridge brain power at its finest. CEO Josh Oppenheimer is a Cambridge MBA; CTO Marek Sirendi holds a PhD in Physics from Cambridge while CSO Marek Rei holds a PhD from Cambridge. He is also a visiting lecturer at Cambridge while COO Weijia Li is another Cambridge MBA.

Newsletter Subscription

Stay informed of the latest news and features